Prokinetic agent (also promotility agent, gastroprokinetic agent, or gastrokinetic agent) are drugs that enhance the stomach/gut's emptying and enhance the gut's contractions/co-ordination. They are used to treat specific gastrointestinal symptoms, including constipation, heartburn, abdominal discomfort, bloating, nausea and vomiting, and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
MARKET DYNAMICS
Factors like increased clinical approval by regulatory bodies for global drug consumption and rise in adult and pediatric motility disorders will propel the prokinetic drugs market's growth. However, risk factors associated with the consumption of drugs like serious cardiac events can hamper the market growth.
MARKET SCOPE
The "Prokinetic Drugs Market Analysis to 2028" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of prokinetic drugs market with detailed market segmentation with type and application. The prokinetic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in prokinetic drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Prokinetic drugs market is segmented on the basis of type and application. On the basis of type, the prokinetic drugs market is divided into metoclopramide, domperidone, cisapride and others. On basis of application, market can be segmented into gastroparesis, constipation, reflux esophagitis and functional dyspepsia.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the prokinetic drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prokinetic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
`The report analyzes factors affecting prokinetic drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the prokinetic drugs market in these regions.
MARKET PLAYERS
The report covers key developments in bacteria filters market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from prokinetic drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for prokinetic drugs in the global market. Below mentioned is the list of few companies engaged in the prokinetic drugs market.
The report also includes the profiles of key players in prokinetic drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Johnson and Johnson
- Sanofi S.A.
- Cadila Pharmaceuticals.
- Hanmi Pharm Co., Ltd.
- Kyowa Kirin Co., Ltd.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Medley Pharmaceuticals Ltd
- Sumitomo Dainippon Pharma Co., Ltd. (Sumitomo Chemical)
- Tranzyme Pharma, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.